Intranasal Drug Delivery Devices Outlook 2034: Key Drivers, Trends, and Market Frontiers
Discover trends, market shifts, and competitive outlooks for the intranasal drug delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Projections for the CAGR of the Intranasal Drug Delivery Devices Market Size From 2025 to 2034?
The market for intranasal drug delivery devices has seen robust growth in the past few years. Its size is projected to increase from $60.27 billion in 2024 to $65.59 billion in 2025, with a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth in the historic period include increasing prevalence of chronic respiratory diseases, patient preference and adherence, convenience of self-administration, use in pediatric treatment, market growth in allergic rhinitis treatment, and broadening range of indications.
The market for intranasal drug delivery devices is poised for substantial growth in the coming years, predicted to reach a value of $92.05 billion by 2029, with an annual compound growth rate (CAGR) of 8.8%. Factors contributing to this projected increase during the forecast period include the escalating elderly population, global rise in respiratory complications, widening use in neurological ailments, the trajectory of personalized medicine, initiatives in preventative healthcare, and market infiltration in developing economies. Key trends expected during the forecast period encompass advancements in drug formulation technologies, concentrative efforts on pediatric and elderly applications, the popularity of self-administering devices, the use of nasal powder inhalers, and the integration of biologics and peptides.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Intranasal Drug Delivery Devices Market?
The escalating frequency of chronic illnesses is anticipated to fuel the expansion of the intranasal drug delivery devices market. Chronic illnesses are those that persist for more than a year, necessitating continuous medical care and potentially restricting everyday activities. Intranasal drug delivery devices, which provide a non-invasive and effective method of administering drugs, are utilized to manage these chronic diseases. These devices directly deliver the medication to the targeted area, making it user-friendly and enabling fast absorption. For instance, the National Health Service, a UK-based government department, noted in June 2024 that in 2023 the number of people in England at risk of developing type 2 diabetes increased by 549,000. This took the total number of people with non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330, a rise of nearly 20% from 3,065,825 in 2022. Hence, the increasing prevalence of chronic diseases is contributing to the growth of the intranasal drug delivery devices market. The augmenting demand for non-invasive drug delivery methods is likely to push the growth of the intranasal drug delivery device market. Non-invasive drug delivery involves introducing pharmaceutical substances into the body without puncturing or making incisions in the skin or mucous membranes. The intranasal drug delivery devices utilized in non-invasive drug delivery enhance the simplicity and effectiveness of drug administration via the nose. These devices leverage the vast network of blood vessels and quick absorption in the nose, thereby increasing drug bioavailability and patient compliance while decreasing the necessity for invasive procedures. For example, The Aesthetic Society, a US-based medical organization, observed in August 2023 that non-surgical procedures in the U.S., such as body contouring, skin treatment, toxins, and micro-needling, grew by 31%, 26%, 24%, and 23% respectively in 2022. Hence, the increasing demand for non-invasive drug delivery methods is bolstering the growth of the intranasal drug delivery device market.
Which Segments in the Intranasal Drug Delivery Devices Offer the Most Growth?
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Subsegments:
1) By Powder Delivery Device: Single-Dose Powder Device, Multi-Dose Powder Device
2) By Liquid Delivery Device: Single-Dose Liquid Device, Multi-Dose Liquid Device
3) By Pressurized Metered-Dose Inhalers (pMDIs): Breath-Actuated PMDIs, Conventional pMDIs
4) By Other Products: Gel Delivery Device, Nebulizers, Nasal Sprays
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13463&type=smp
What Are the Fastest-Growing Geographies in the Intranasal Drug Delivery Devices Market?
North America was the largest region in the intranasal drug delivery devices market in 2024. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Intranasal Drug Delivery Devices Industry?
Key pharmaceutical players in the nasal drug delivery technology market are continually innovating, creating new and enhanced products to provide customers with alternative ways for drug administration and maintain their standing in the market. As an example, in January 2023, the U.S.-based pharmaceutical and drug delivery company, AptarGroup, Inc., introduced APF Futurity, which is the first recyclable, metal-free, multidose nasal spray used to distribute nasal saline and similar over-the-counter (OTC) formulations. APF Futurity is produced from polyolefin materials and lacks any metal components or elements that can disrupt recycling, thus diminishing the requirement for separation in recycling channels and supporting the increase of high-quality recycled materials. The most distinctive feature of this product is its recyclable design making it a highly recycle-friendly nasal spray pump. It has earned a Class AA certification from cyclos-HTP for recycling channels throughout Europe.
View the full report here:
What Are the Key Elements That Define the Intranasal Drug Delivery Devices Market?
Intranasal drug delivery devices are medical devices that deliver medications into the nasal cavity. These devices are intended to administer medications directly to the nasal mucosa, which is highly vascularized and has a huge surface area, allowing the drug to be absorbed into the bloodstream quickly. It delivers drugs or therapeutic substances in various forms, including sprays, powders, or liquid solutions, directly into the nasal cavity.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13463
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
